Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet therapy for controlling HIV infection. This medication unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the virus's ability to multiply within the body, considerably reducing the viral quantity. For many indiv